Invention Grant
US08741336B2 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
有权
生物同步透皮药物输送用于长寿,抗衰老,疲劳管理,肥胖,减肥,体重管理,交付营养药物和治疗高血糖症,阿尔茨海默病,睡眠障碍,帕金森病,艾滋病,癫痫,注意力缺陷障碍,尼古丁 成瘾,癌症,头痛和疼痛控制,哮喘,心绞痛,高血压,抑郁症,感冒,感冒等
- Patent Title: Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
- Patent Title (中): 生物同步透皮药物输送用于长寿,抗衰老,疲劳管理,肥胖,减肥,体重管理,交付营养药物和治疗高血糖症,阿尔茨海默病,睡眠障碍,帕金森病,艾滋病,癫痫,注意力缺陷障碍,尼古丁 成瘾,癌症,头痛和疼痛控制,哮喘,心绞痛,高血压,抑郁症,感冒,感冒等
-
Application No.: US13488195Application Date: 2012-06-04
-
Publication No.: US08741336B2Publication Date: 2014-06-03
- Inventor: Guy DiPierro , Steven A. Giannos
- Applicant: Guy DiPierro , Steven A. Giannos
- Applicant Address: US MA Cambridge
- Assignee: Chrono Therapeutics, Inc.
- Current Assignee: Chrono Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Foley & Lardner LLP
- Main IPC: A61K9/70
- IPC: A61K9/70 ; A61N1/30

Abstract:
Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, plant extracts, botanicals, nutraceuticals, cosmeceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.
Public/Granted literature
Information query